Evidence map›Paper›PMID 36432599›Full record

Trial reportNutrients2022

Exposure to (Poly)phenol Metabolites after a Fruit and Vegetable Supplement Intake: A Double-Blind, Cross-Over, Randomized Trial.

Cindy Romain, Letizia Bresciani, Jananee Muralidharan, Pedro Mena, Linda H Chung, Pedro E Alcaraz, Daniele Del Rio, Julien Cases

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cindy RomainInnovation and Scientific Affairs, Fytexia, 34350 Vendres, France.ORCID 0000-0002-3922-8438
Letizia BrescianiHuman Nutrition Unit, Department of Food & Drug, University of Parma, Via Volturno 39, 43125 Parma, Italy.ORCID 0000-0002-7768-4987
Jananee MuralidharanInnovation and Scientific Affairs, Fytexia, 34350 Vendres, France.
Pedro MenaHuman Nutrition Unit, Department of Food & Drug, University of Parma, Via Volturno 39, 43125 Parma, Italy.ORCID 0000-0003-2150-2977
Linda H ChungResearch Center for High Performance Sport, UCAM Universidad Católica de Murcia, 30107 Murcia, Spain.ORCID 0000-0001-5899-9097
Pedro E AlcarazResearch Center for High Performance Sport, UCAM Universidad Católica de Murcia, 30107 Murcia, Spain.ORCID 0000-0002-9792-6656
Daniele Del RioHuman Nutrition Unit, Department of Food & Drug, University of Parma, Via Volturno 39, 43125 Parma, Italy.ORCID 0000-0001-5394-1259
Julien CasesInnovation and Scientific Affairs, Fytexia, 34350 Vendres, France.ORCID 0000-0002-6368-250X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary (poly)phenol intake derived from the daily consumption of five portions of fruits and vegetables could protect against the development of non-communicable diseases. However, the general population does not meet the recommended intake. Supplementation with (poly)phenol-rich ingredients, within a varied and balanced diet, could help in filling this nutritional gap. This study aimed to validate the proof-of-concept of a (poly)phenolic supplementation developed to enhance the daily consumption of potentially bioactive compounds. Oxxynea

Indexed as

FruitVegetablesCross-Over StudiesDietary SupplementsHumansPhenolPhenolsPolyphenolsTandem Mass SpectrometryPhenolPhenolsPolyphenolsbioavailabilityinter-individual variabilitypharmacokinetics(poly)phenol-based supplementurinary excretion

Identifiers

PMID36432599
PMCPMC9692523

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.